Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis

OBJECTIVES: Interferon beta (IFNβ) therapy is effective in multiple sclerosis and murine models of arthritis. Surprisingly, systemic IFNβ treatment induces only minimal improvement in rheumatoid arthritis (RA). To explain this paradox, the authors evaluated the mechanism of IFNβ benefit in passive K...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Corr, Maripat, Boyle, David L, Ronacher, Lisa M, Lew, Brian R, van Baarsen, Lisa G, Tak, Paul P, Firestein, Gary S
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728888/
https://ncbi.nlm.nih.gov/pubmed/21216819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.141077
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky